CL2011000186A1 - Metodos para eliminar o prevenir el crecimiento de un microbio en un sustrato mediante la aplicacion de compuestos derivados de tetrakis (n-alquilpiridinio)- porfirina; composicion topica que comprende dicho compuesto; y metodo para prevenir y tratar una infeccion de la piel en un sujeto. - Google Patents

Metodos para eliminar o prevenir el crecimiento de un microbio en un sustrato mediante la aplicacion de compuestos derivados de tetrakis (n-alquilpiridinio)- porfirina; composicion topica que comprende dicho compuesto; y metodo para prevenir y tratar una infeccion de la piel en un sujeto.

Info

Publication number
CL2011000186A1
CL2011000186A1 CL2011000186A CL2011000186A CL2011000186A1 CL 2011000186 A1 CL2011000186 A1 CL 2011000186A1 CL 2011000186 A CL2011000186 A CL 2011000186A CL 2011000186 A CL2011000186 A CL 2011000186A CL 2011000186 A1 CL2011000186 A1 CL 2011000186A1
Authority
CL
Chile
Prior art keywords
alkylpyridinium
microbe
tetrakis
eliminating
treat
Prior art date
Application number
CL2011000186A
Other languages
English (en)
Inventor
Glenn Prestwich
Jerry C Bommer
Charles Testa
Original Assignee
Frontier Scient Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41349499&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2011000186(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Frontier Scient Inc filed Critical Frontier Scient Inc
Publication of CL2011000186A1 publication Critical patent/CL2011000186A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Método para eliminar o prevenir el crecimiento de un microbio en un sustrato mediante la aplicación de compuestos derivados de tetrakis (n-alquilpiridinio)- porfirina; composición tópica que comprende dicho compuesto; y método para prevenir y tratar una infección de la piel en un sujeto.
CL2011000186A 2008-07-29 2011-01-28 Metodos para eliminar o prevenir el crecimiento de un microbio en un sustrato mediante la aplicacion de compuestos derivados de tetrakis (n-alquilpiridinio)- porfirina; composicion topica que comprende dicho compuesto; y metodo para prevenir y tratar una infeccion de la piel en un sujeto. CL2011000186A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8440308P 2008-07-29 2008-07-29

Publications (1)

Publication Number Publication Date
CL2011000186A1 true CL2011000186A1 (es) 2012-03-02

Family

ID=41349499

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000186A CL2011000186A1 (es) 2008-07-29 2011-01-28 Metodos para eliminar o prevenir el crecimiento de un microbio en un sustrato mediante la aplicacion de compuestos derivados de tetrakis (n-alquilpiridinio)- porfirina; composicion topica que comprende dicho compuesto; y metodo para prevenir y tratar una infeccion de la piel en un sujeto.

Country Status (9)

Country Link
US (1) US8633311B2 (es)
EP (1) EP2317857B1 (es)
JP (1) JP2012504553A (es)
CN (1) CN102245027A (es)
CA (1) CA2733001A1 (es)
CL (1) CL2011000186A1 (es)
ES (1) ES2620442T3 (es)
MX (1) MX2011001005A (es)
WO (1) WO2010014728A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102159214A (zh) 2008-07-16 2011-08-17 药品循环公司 用于实体肿瘤的治疗的布鲁顿酪氨酸激酶的抑制剂
MX380504B (es) 2010-06-03 2025-03-12 Pharmacyclics Llc El uso de inhibidores de la tirosina quinasa de bruton (btk).
KR20140048968A (ko) 2011-07-13 2014-04-24 파마시클릭스, 인코포레이티드 브루톤형 티로신 키나제의 억제제
FR2987259B1 (fr) * 2012-02-29 2014-02-21 Oreal Utilisation comme agent antipelliculaire de composes catalytiques d'oxydation choisi parmi les porphyrines, les phthalocyanines et les porphyrazines
JP2015522554A (ja) 2012-06-04 2015-08-06 サンコー・エナジー・インコーポレーテッド パラフィン油及び沈降防止剤を含む製剤
MA37711A1 (fr) 2012-06-04 2017-05-31 Pharmacyclics Inc Formes cristallines d'un inhibiteur de tyrosine kinase de bruton
HK1206073A1 (en) 2012-07-24 2015-12-31 药品循环有限责任公司 Mutations associated with resistance to inhibitors of bruton's tyrosine kinase (btk)
US20160008468A1 (en) * 2013-02-27 2016-01-14 Thomas J Lewis Disease detection and treatment through activation of compounds using external energy
CA2920534A1 (en) 2013-08-12 2015-02-19 Pharmacyclics Llc Methods for the treatment of her2 amplified cancer
CN103601727A (zh) * 2013-10-23 2014-02-26 中国医学科学院生物医学工程研究所 一种新型的胺类化合物修饰原卟啉的用途
CN103800437A (zh) * 2013-12-31 2014-05-21 芜湖乐锐思信息咨询有限公司 一种治疗虫霉病的中药
US9885086B2 (en) 2014-03-20 2018-02-06 Pharmacyclics Llc Phospholipase C gamma 2 and resistance associated mutations
US9545407B2 (en) 2014-08-07 2017-01-17 Pharmacyclics Llc Formulations of a bruton's tyrosine kinase inhibitor
IL315294A (en) 2015-03-03 2024-10-01 Pharmacyclics Llc Pharmaceutical formulations of proton tyrosine kinase inhibitor
CN105830760B (zh) * 2016-01-28 2019-01-11 中国计量学院 一种成功使茭白植株孕茭的菰黑粉菌人工接种方法
EP3664892A4 (en) 2017-08-08 2021-04-28 Board of Trustees of Michigan State University TUNED LUMINESCENT ORGANIC SALT FOR ENHANCED IMAGING AND PHOTODYNAMIC THERAPY
JP7241736B2 (ja) * 2017-08-16 2023-03-17 サンコー・エナジー・インコーポレイテッド 植物における微生物病原体の光力学的阻害
CN108179114B (zh) * 2017-11-27 2021-08-20 南京晓庄学院 产抗厌氧菌化合物的菌株和发酵方法、抗厌氧菌化合物提取及制备方法和使用方法
CN109136386B (zh) * 2018-07-25 2021-12-24 华南农业大学 一种用于卡耶塔环孢子虫快速分型和溯源的定量pcr方法及试剂盒
AU2020211650B2 (en) 2019-01-25 2025-01-30 Nutrien Ag Solutions (Canada) Inc. Photosensitizer compounds, methods of manufacture and application to plants
JP7588289B2 (ja) * 2019-02-15 2024-11-22 ニュートリエン・エージー・ソリューションズ・（カナダ）・インコーポレイテッド 植物の健康を増進するプロトポルフィリンｉｘ誘導体及びその使用
CN110205264B (zh) * 2019-05-22 2020-09-04 暨南大学 水霉拮抗菌jd03及其发酵液与活性化合物在制备防治水霉病的产品中的应用
CN110846248A (zh) * 2019-11-19 2020-02-28 天津大学 一种用于多环芳烃降解的人工混菌体系及其应用方法
CN111172047B (zh) * 2020-02-12 2021-08-03 中国农业大学 一种桔假丝酵母菌及其应用
NO347612B1 (en) * 2020-06-17 2024-01-29 Mowi ASA Method for removing crustacean ectoparasites from farmed salmonid fish using water-soluble tetrapyrrole compounds and light

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9114290D0 (en) 1991-07-02 1991-08-21 Courtaulds Plc Polymer compositions
WO1998030102A1 (en) 1997-01-09 1998-07-16 Emory University Non-iron metalloporphyrins and methods of use
US6462070B1 (en) 1997-03-06 2002-10-08 The General Hospital Corporation Photosensitizer conjugates for pathogen targeting
IT1297080B1 (it) 1997-11-26 1999-08-03 Andrea Carnevali Composizione per il trattamento di ustioni, eritemi solari, abrasioni, piaghe e irritazioni cutanee
US8974363B2 (en) 1997-12-11 2015-03-10 Provectus Pharmatech, Inc. Topical medicaments and methods for photodynamic treatment of disease
ATE335513T1 (de) 1998-10-16 2006-09-15 Gen Hospital Corp Photosensitizer-konjugate zur zielrichtung von intrazellulare pathogene
DE19910561A1 (de) 1999-03-10 2000-09-14 Schaffer Moshe Verwendung von Porphyrinderivaten in Aquarien
DE19962505A1 (de) 1999-12-23 2001-07-05 Schaffer Moshe Mikrobizide Wirkung von Porphyrinen im Dunkeln
US20020022215A1 (en) * 2000-06-29 2002-02-21 Sobsey Mark D. Inactivation of small non-enveloped viruses and other microbial pathogens by porphyrins
US6573258B2 (en) * 2000-09-27 2003-06-03 Frontier Scientific, Inc. Photodynamic porphyrin antimicrobial agents
US6884797B2 (en) 2001-03-30 2005-04-26 Robert F. Hofmann Targeted oxidative therapeutic formulation
US7439271B2 (en) * 2001-06-27 2008-10-21 The Gillette Company Reduction of hair growth
ITVR20010110A1 (it) 2001-10-23 2003-04-23 Giulio Jori Procedimento di sterilizzazione microbiologica dell'acqua mediante agenti fotoattivabili.
EP1480638A2 (en) 2002-01-08 2004-12-01 Emory University Porphyrins with virucidal activity
GB2397067B (en) 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
NL1022597C2 (nl) 2003-02-05 2004-08-06 Photobiochem N V Toepassing van een fotosensitizerverbinding voor de bereiding van een farmaceutisch preparaat, werkwijze voor het bereiden van een farmaceutisch preparaat en een werkwijze voor het behandelen van een zoogdier.
EP1457113A1 (en) 2003-03-12 2004-09-15 Salbert Co Ltd Alkylated porphyrins as pesticides acting both in the presence and absence of light
EP1631572A2 (en) 2003-06-06 2006-03-08 Eukarion, Inc. Orally bioavailable low molecular weight metalloporphyrins as antioxidants
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
CA2632183A1 (en) 2005-08-25 2007-03-01 Philip R. Houle Treatment systems for delivery of sensitizer solutions
US20080015189A1 (en) 2006-06-20 2008-01-17 The General Hospital Corporation Antimicrobial photoinactivation using chalcogen analogs of benzo(A)phenoxazinium dyes
GB0712287D0 (en) 2007-06-22 2007-08-01 Ucl Business Plc Antimicrobial Conjugates
US8440309B2 (en) 2011-01-31 2013-05-14 Confluent Surgical, Inc. Crosslinked polymers with the crosslinker as therapeutic for sustained release

Also Published As

Publication number Publication date
US8633311B2 (en) 2014-01-21
US20120016289A1 (en) 2012-01-19
WO2010014728A1 (en) 2010-02-04
MX2011001005A (es) 2011-09-01
EP2317857B1 (en) 2016-12-28
JP2012504553A (ja) 2012-02-23
CN102245027A (zh) 2011-11-16
EP2317857A1 (en) 2011-05-11
CA2733001A1 (en) 2010-02-04
ES2620442T3 (es) 2017-06-28

Similar Documents

Publication Publication Date Title
CL2009000426A1 (es) Compuestos derivados de carbociclil/heterociclil-piridin-2-il-urea, inhibidores de topoisomerasa iv bacteriana; composicion farmaceutica; y su uso para el tratamiento de infecciones bacterianas
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
UY32062A (es) Inhibidores de beta-secretasa
ECSP11010980A (es) Compuestos heteroaromáticos espirocíclicos fusionados para el tratamiento de infecciones bacterianas
BR112012023021A2 (pt) compostos de indazol e seus usos
UA115126C2 (uk) Пестицидні композиції і способи, які їх стосуються
CR20120125A (es) Combinaciones fungicidas sinérgicas que contienen una ditiino-tetracarboxamida fungicida
CL2008003848A1 (es) Compuestos derivados de fenilo o heteroarilo bis-sulfonilamino sustituidos, inhibidores de prostaglandina e sintasa-1 microsomal; composicion farmaceutica; procedimiento de preparacion; procedimiento de preparacion de la composicion farmaceutica; y uso en el tratamiento del dolor agudo o cronico, dolor nociceptivo o dolor neuropatico.
ECSP10010494A (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa
CL2008003653A1 (es) Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
CL2011000604A1 (es) Compuestos derivados de multiheteroarilo, inhibidores de h-pgds, composicion farmaceutica que los comprende; utiles en el tratamiento de enfermedades inflamatorias y alergicas.
PA8850801A1 (es) Compuestos útiles para inhibir chk1
BRPI1106572B8 (pt) Composições que compreendem um retinoide e um inibidor de nfkb e seus métodos de uso
MX2013005995A (es) Composicion topica que promueve la melanina.
EA201200484A1 (ru) Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином
EA201071166A1 (ru) Контролируемое высвобождение активных агентов из олеосом
CL2009000803A1 (es) Uso de una variante de igf-1 pegilada para tratar, prevenir un trastorno neuromuscular; metodo para el tratamiento, prevencion y/o demora de un trastorno neuromuscular; composicion que comprende la variante de igf-1 modificada
DOP2011000050A (es) Inhibidores de cmet
GB2525835A (en) Composition comprising a diindolymethane and a retinoid to treat a skin condition
BR112012007798A2 (pt) microcápsulas estáveis e composição para aplicação tópica e método para a preparação de microcápsulas
WO2013162933A3 (en) Active halogen antimicrobial composition and method of use
CL2020000859A1 (es) Derivados de ácido glucónico para ser usados en el tratamiento y/o prevención de infecciones microbianas.
AR075301A1 (es) Composicion y metodo para controlar enfermedades de plantas
CR20110022A (es) Nuevas posibilidades de lucha contra la giardiasis
AU2018258588A8 (en) Inhibitors of TRIM33 and methods of use